-
7
Denmark's bid to ditch Office for open-source collapses in under six months
(tomshardware.com)
-
4
Partial Operator Precedence (Zig Devlog)
(ziglang.org)
-
15
Elon Musk Just Dumped Another $76M into the Midterms
(wired.com)
-
32
Third Risk
(thirdrisk.org)
-
122
Proton Flock Camera Map
(proton.me)
-
177
Show HN: I put employees inside S&P 500 market-cap bubbles
(bigwhalehunting.com)
-
6
Iterating Backwards in C
(davidpriver.com)
-
388
The foolishness of "natural language programming" (1978)
(cs.utexas.edu)
-
120
The Importance of Limitations for Creativity and Learning (2023)
(ratfactor.com)
-
30
'modern-day slavery' in the Congo powers the rechargeable battery economy (2023)
(npr.org)
-
191
Apple Security Research Device
(security.apple.com)
-
543
America has lost 200k of jobs in media, film and the arts. How much is AI?
(apricitas.io)
-
82
Show HN: Impossible Machines: declaratively program the physical world
(impossiblemachines.xyz)
-
36
Making My Blog Readable by AI Agents
(deallocatedobjects.com)
-
29
warp.dev Breached
(twitter.com)
-
5
Programming Is Not a Skill
(ethang.dev)
-
110
Show HN: Making a smart TV dumb and then smart
(github.com)
-
12
Show HN: RainbowSay – Learn, teach, research languages live with shows you love
(rainbowsay.ai)
-
15
Show HN: AgentTrust – Zero-trust security and human approvals for AI agents
(github.com)
-
81
Proton to 'Re-Interview' Staff About AI to See Who Gets to Keep Their Job
(404media.co)
-
9
Show HN: Ultimidi – piano learning web game
(game.ultimidi.com)
-
61
One Man's Pan Am 747 Replica [video]
(youtube.com)
-
3
Generates polished SVGs with optional WebGL shaders and 3D effects
(skills.wheresryan.sh)
-
229
CVE Tracker
(cve.0xosprey.com)
-
60
DNS: A Replacement for Finger
(altchan.org)
-
7
Why remote roles are becoming extinct in 2026?
-
64
A few thoughts on intensity (2024)
(tylerhogge.com)
-
202
Listen and read USA nuclear forces Emergency Action Messages, heard on 11175 kHz
(missileer.watch)
-
24
Microsoft is offering buyouts to 60k workers
(twitter.com)
-
211
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
(arstechnica.com)